NR4A1 and breast cancer: Ralstonia pickettii still dominated in both types of breast cancer, but its relative abundance was reduced in hormone-receptor-positive breast tissues (19.03% in hormone-receptor-positive vs. 25.83% in hormone receptor-negative) (Figure 5A).